Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CPSI Biotech, officially known as Cell Preservation Services, Inc., is a biotechnology and medical device company specializing in the development of advanced cryopreservation and cryoablation technologies. The company provides specialized media and protocols for the long-term storage of cells and tissues, while also developing the Pressure-Enhanced Cryoablation (PECA) platform for the minimally invasive treatment of solid tumors. Their product portfolio includes the FrostBite cryoablation system and various cell preservation solutions designed to improve post-thaw viability and functionality. CPSI Biotech serves the research, clinical, and industrial sectors of the life sciences industry. The company is headquartered in Owego, New York, and maintains a strong focus on translational medicine through collaborations with academic and clinical partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cell Preservation Services.